WCN26-3013 PLASMA MATRIX METALLOPROTEINASE-2 AND LOWER DEPRESSIVE SYMPTOMS IN PATIENTS UNDERGOING HEMODIALYSIS

Read full text Summarise with VIRAT
Authors: Jae‐Hong Ryoo, 이동영
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Matrix metalloproteinases-2 and matrix metalloproteinases-9 have major roles in the degradation of the extracellular matrix, a primary component of tissue structure and are concerned with inflammation. Patients undergoing hemodialysis are prevalent of depression. Inflammation is one of the leading causes of depression. This study explored the connection between plasma matrix metalloproteinases-2/matrix metalloproteinases-9 and depression in patients undergoing hemodialysis.

Fields of Study & Subjects

Dialysis and Renal Disease Management Tryptophan and brain disorders Protease and Inhibitor Mechanisms

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104980–104980
Publication date
25 March 2026
Language
EN